1. Trang chủ
  2. » Kỹ Thuật - Công Nghệ

Biochemistry, 4th Edition P72 pps

10 163 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 10
Dung lượng 684,79 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

High levels of phosphate in the cell favor glycogen breakdown and prevent the phos-phorylase reaction from synthesizing glycogen in vivo, despite the fact that G° for the phosphorylase r

Trang 1

hibition by fructose-2,6-bisphosphate, whereas phosphofructokinase is allosterically

activated by fructose-2,6-bisphosphate The combination of these effects should

per-mit either phosphofructokinase or fructose-1,6-bisphosphatase (but not both) to

operate at any one time and should thus prevent futile cycling For instance, in

the fasting state, when food (that is, glucose) intake is zero, phosphofructokinase

(and therefore glycolysis) is inactive due to the low concentration of

fructose-2,6-bisphosphate In the liver, gluconeogenesis operates to provide glucose for the

brain However, in the fed state, up to 30% of fructose-1,6-bisphosphate formed

from phosphofructokinase is recycled back to fructose-6-P (and then to glucose)

Because the dependence of bisphosphatase activity on

fructose-1,6-bisphosphate is sigmoidal in the presence of fructose-2,6-fructose-1,6-bisphosphate (see

Figure 22.9), substrate cycling occurs only at relatively high levels of

fructose-1,6-bisphosphate Substrate cycling in this case prevents the accumulation of excessively

high levels of fructose-1,6-bisphosphate

Dietary Starch Breakdown Provides Metabolic Energy

As noted earlier, well-fed adult human beings normally metabolize about 160 grams

of carbohydrates each day A balanced diet easily provides this amount, mostly in the

form of starch If too little carbohydrate is supplied by the diet, glycogen reserves in

liver and muscle tissue can also be mobilized The reactions by which ingested starch

and glycogen are digested are shown in Figure 22.11 The enzyme known as

␣-amy-laseis an important component of saliva and pancreatic juice (␤-Amylase is found

in plants The - and -designations for these enzymes serve only to distinguish the

two and do not refer to glycosidic linkage nomenclature.) -Amylase is an

endogly-cosidase that hydrolyzes (1⎯→4) linkages of amylopectin and glycogen at random

positions, eventually producing a mixture of maltose, maltotriose [with three

(1⎯ →4)-linked glucose residues], and other small oligosaccharides -Amylase can

-Amylase

-Amylase

-(1 6)-glucosidase

FIGURE 22.11 (a) The sites of hydrolysis of starch by

- and -amylase are indicated (b) Glycogenin is a

glycosyltransferase that initiates eukaryotic glycogen synthesis from glucose Bound UDP-glucose (blue) and

Mn 2 ion (purple) are shown (pdb id  1LL2).

Trang 2

cleave on either side of an amylopectin branch point, but activity is reduced in highly branched regions of the polysaccharide and stops four residues from any branch point

The highly branched polysaccharides that are left after extensive exposure to

-amylase are called limit dextrins These structures can be further degraded by the

action of a debranching enzyme, which carries out two distinct reactions The first of these, known as oligo(␣1,4→␣1,4) glucanotransferase activity, removes a

trisaccha-ride unit and transfers this group to the end of another, nearby branch (Figure 22.12) This leaves a single glucose residue in (1⎯→6) linkage to the main chain The

␣(1⎯→6) glucosidase activity of the debranching enzyme then cleaves this residue

from the chain, leaving a polysaccharide chain with one branch fewer Repetition of this sequence of events leads to complete degradation of the polysaccharide

-Amylase is an exoglycosidase that cleaves maltose units from the free,

nonre-ducing ends of amylopectin branches, as in Figure 22.11 Like -amylase, however,

-amylase does not cleave either the (1⎯→6) bonds at the branch points or the

(1⎯→4) linkages near the branch points

Metabolism of Tissue Glycogen Is Regulated

Digestion itself is a highly efficient process in which almost 100% of ingested food

is absorbed and metabolized Digestive breakdown of starch is an unregulated process On the other hand, tissue glycogen represents an important reservoir of potential energy, and it should be no surprise that the reactions involved in its degradation and synthesis are carefully controlled and regulated Glycogen re-serves in liver and muscle tissue are stored in the cytosol as granules exhibiting a molecular weight range from 6 106 to 1600 106 These granular aggregates contain the enzymes required to synthesize and catabolize the glycogen, as well as all the enzymes of glycolysis

The principal enzyme of glycogen catabolism is glycogen phosphorylase, a highly

regulated enzyme that was discussed extensively in Chapter 15 The glycogen phos-phorylase reaction (Figure 22.13) involves phosphorolysis at a nonreducing end of

a glycogen polymer The standard-state free energy change for this reaction is

O O

O

O O

O O

O

O O

O

O

O O

HO

O O

O O

O

O

O O

O O

O

O

O O

O O

O O

O

O

O

O

O O

O

O

O

O

HO

O O

HO

HO

Limit branch

Limit dextrin

Debranching enzyme

(1 6)-glucosidase activity

of debranching enzyme cleaves this residue

Further cleavage by -amylase

FIGURE 22.12 The reactions of debranching enzyme.

Transfer of a group of three (1⎯→4)-linked glucose

residues from a limit branch to another branch is

fol-lowed by cleavage of the (1⎯→6) bond of the residue

that remains at the branch point.

Trang 3

3.1 kJ/mol, but the intracellular ratio of [Pi] to [glucose-1-P] approaches 100, and

thus the actual G in vivo is approximately 6 kJ/mol There is an energetic

ad-vantage to the cell in this phosphorolysis reaction If glycogen breakdown were

hy-drolytic and yielded glucose as a product, it would be necessary to phosphorylate

the product glucose (with the expenditure of a molecule of ATP) to initiate its

gly-colytic degradation

The glycogen phosphorylase reaction degrades glycogen to produce limit

dex-trins, which are further degraded by debranching enzyme, as already described

Animals synthesize and store glycogen when glucose levels are high, but the

syn-thetic pathway is not merely a reversal of the glycogen phosphorylase reaction High

levels of phosphate in the cell favor glycogen breakdown and prevent the

phos-phorylase reaction from synthesizing glycogen in vivo, despite the fact that G° for

the phosphorylase reaction actually favors glycogen synthesis Hence, another

reac-tion pathway must be employed in the cell for the net synthesis of glycogen In

essence, this pathway must activate glucose units for transfer to glycogen chains

Glucose Units Are Activated for Transfer by Formation

of Sugar Nucleotides

We are familiar with several examples of chemical activation as a strategy for group

transfer reactions Acetyl-CoA is an activated form of acetate; biotin and

tetrahydro-folate activate one-carbon groups for transfer; and ATP is an activated form of

phos-phate Luis Leloir, a biochemist in Argentina, showed in the 1950s that glycogen

syn-thesis depended upon sugar nucleotides, which may be thought of as activated forms

of sugar units For example, formation of an ester linkage between the C-1 hydroxyl

group and the -phosphate of UDP activates the glucose moiety of UDP–glucose.

HOCH2

O

H

H

OH O

H

O

O–

O

O–

CH2 O

H

H

N

O

HN

O

Uridine diphosphate glucose

(UDPG)

CH2OH O

O

CH2OH O

O

CH2OH O

O

CH2OH O

O

+

CH2OH

O

CH2OH O

O

CH2OH O

O

CH2OH O

O OPO3–

P

OH HO

HO

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH

OH HO

n

n – 1

Uridine diphosphate glucose (UDP–glucose).

Trang 4

UDP–Glucose Synthesis Is Driven by Pyrophosphate Hydrolysis

Sugar nucleotides are formed from sugar-1-phosphates and nucleoside

triphos-phates by specific pyrophosphorylase enzymes (Figure 22.14) For example, UDP– glucose pyrophosphorylasecatalyzes the formation of UDP–glucose from glucose-1-phosphate and uridine 5-triphosphate:

Glucose-1-P UTP ⎯⎯→ UDP–glucose  pyrophosphate The reaction proceeds via attack by a phosphate oxygen of glucose-1-phosphate on the-phosphorus of UTP, with departure of the pyrophosphate anion The reaction

is a reversible one, but—as is the case for many biosynthetic reactions—it is driven forward by subsequent hydrolysis of pyrophosphate:

Pyrophosphate H2O⎯⎯→ 2 Pi

The net reaction for sugar nucleotide formation (combining the preceding two equations) is thus

Glucose-1-P UTP  H2O⎯⎯→ UDP–glucose  2 Pi

Sugar nucleotides of this type act as donors of sugar units in the biosynthesis of oligosaccharides and polysaccharides In animals, UDP–glucose is the donor of glu-cose units for glycogen synthesis, but ADP–gluglu-cose is the gluglu-cose source for starch synthesis in plants

Glycogen Synthase Catalyzes Formation of ␣(1⎯ →4) Glycosidic Bonds in Glycogen

The very large glycogen polymer is built around a tiny protein core The first

glu-cose residue is covalently joined to the protein glycogenin (see Figure 22.11b) via

an acetal linkage to a tyrosine–OH group on the protein Sugar units can then be

added by the action of glycogen synthase The reaction involves transfer of a

glu-P glu-P

CH2OH O

OH HO

HO

O

O–

O

–O

O

–O

O

–O

O

H

H

N

HN

O O

P

2

CH2OH O

OH HO

HO

O

–O

O

–O

O

H

H

N

HN

O O

UTP

Glucose-1-P

UDP–glucose pyrophosphorylase

UDP–glucose

ANIMATED FIGURE 22.14 The UDP–

glucose pyrophosphorylase reaction is a

phospho-anhydride exchange, with a phosphoryl oxygen of

glucose-1-P attacking the -phosphorus of UTP to form

UDP–glucose and pyrophosphate See this figure

ani-mated at www.cengage.com/login.

Glycogen synthase from Agrobacterium tumefaciens

consists of two Rossman folds (see Chapter 16)

sepa-rated by a deep cleft that includes the active site

(shown here with bound ADP, purple) (pdb id  1RZU).

Trang 5

cosyl unit from UDP–glucose to the C-4 hydroxyl group at a nonreducing end of a

glycogen strand The mechanism proceeds by cleavage of the COO bond between

the glucose moiety and the -phosphate of UDP–glucose, leaving an oxonium ion

intermediate, which is rapidly attacked by the C-4 hydroxyl oxygen of a terminal

glu-cose unit on glycogen (Figure 22.15) The reaction is exergonic and has a G° of

13.3 kJ/mol

Glycogen Branching Occurs by Transfer of Terminal Chain Segments

Glycogen is a branched polymer of glucose units The branches arise from

(1⎯→6) linkages, which occur every 8 to 12 residues As noted in Chapter 7, the

branches provide multiple sites for rapid degradation or elongation of the

poly-mer and also increase its solubility Glycogen branches are formed by

amylo-HUMAN BIOCHEMISTRY

Advanced Glycation End Products—A Serious Complication of Diabetes

Covalent linkage of sugars to proteins to form glycoproteins

nor-mally occurs through the action of enzymes that use sugar

nucleo-tides as substrates However, sugars may also react

nonenzymati-cally with proteins The C-1 carbonyl group of glucose forms Schiff

base linkages with lysine side chains of proteins These Schiff base

adducts undergo Amadori rearrangements and subsequent

oxida-tions to form irreversible “glycation” products, including

carboxy-methyllysine and pentosidine derivatives (see accompanying

fig-ure) These advanced glycation end products (AGEs) can alter

the function of the protein Such AGE-dependent changes are thought to contribute to circulation, joint, and vision problems in people with diabetes

Nonenzymatic glycation of hemoglobin is a better diagnostic yardstick for type-2 diabetes than serum glucose levels Red blood cells have an average life expectancy of about 4 months By mea-suring the concentration of “glycated hemoglobin” in a patient, it

is possible to determine the average glucose concentration in the blood over the past several months

CH2OH

(CH2)4 (CH2)3

CH

H

CHO

OH C

N

O

NH2

CH

H

CH2OH

H

Protein

+

+

+

Protein

N

CH2OH

CH2

O C H

H

Protein

H N

N

H

O C HN C N

(CH2)4

NH

N

H C C

CH2

COO–

Rearrangement leads to irreversibly glycated proteins

Schiff base

Pentosidine Carboxymethyllysine

Other advanced glycation end products

Trang 6

(1,4→1,6)-transglycosylase, also known as branching enzyme The reaction involves

the transfer of a 6- or 7-residue segment from the nonreducing end of a linear chain at least 11 residues in length to the C-6 hydroxyl of a glucose residue of the same chain or another chain (Figure 22.16) For each branching reaction, the resulting polymer has gained a new terminus at which growth can occur

Glycogen Metabolism Is Highly Regulated

Synthesis and degradation of glycogen must be carefully controlled so that this im-portant energy reservoir can properly serve the metabolic needs of the organism Glu-cose is the principal metabolic fuel for the brain, and the concentration of gluGlu-cose in

circulating blood must be maintained at about 5 mM for this purpose Glucose derived

from glycogen breakdown is also a primary energy source for muscle contraction Con-trol of glycogen metabolism is effected via reciprocal regulation of glycogen phospho-rylase and glycogen synthase Thus, activation of glycogen phosphophospho-rylase is tightly linked to inhibition of glycogen synthase, and vice versa Regulation involves both al-losteric control and covalent modification, with the latter being under hormonal con-trol The regulation of glycogen phosphorylase is discussed in detail in Chapter 15

Glycogen Synthase Is Regulated by Covalent Modification

Glycogen synthase also exists in two distinct forms that can be interconverted by the

action of specific enzymes: active, dephosphorylated glycogen synthase I P–independent) and less active, phosphorylated glycogen synthase D

(glucose-6-H+

O

OH HO

CH2OH

HO

O–

O

O–

O

O N O

O

HN

OH OH

H H

O

OH O

CH2OH

HO

O

O

OH O

CH2OH

HO

O

OH O

CH2OH

HO

O

OH HO

CH2OH

HO

O

OH O

CH2OH

HO

O

O

OH O

CH2OH

HO

O

OH HO

CH2OH

HO

O

OH HO

CH2OH

HO

+

UDP–glucose

UDP

Glycogen (n residues)

Oxonium ion intermediate

Glycogen (n+ 1 residues)

ANIMATED FIGURE 22.15 The glycogen synthase reaction Cleavage of the C OO bond of UDP–glucose yields an oxonium intermediate Attack by the hydroxyl oxygen of the terminal residue of a

glycogen molecule completes the reaction See this figure animated at www.cengage.com/login.

(1 4)-terminal

chains of glycogen

Branching enzyme cuts here

and transfers

a seven-residue

terminal segment

to a C(6)–OH

group

FIGURE 22.16 Formation of glycogen branches by the

branching enzyme Six- or seven-residue segments of

a growing glycogen chain are transferred to the C-6

hydroxyl group of a glucose residue on the same or a

nearby chain.

Trang 7

P–dependent) The phosphorylated form can be allosterically activated by

glucose-6-phosphate, but the unphosphorylated enzyme is insensitive to this allosteric effector

(Figure 22.17) The nature of phosphorylation is complex (Figure 22.17a) At least

nine serine residues on the enzyme appear to be subject to phosphorylation, each

site’s phosphorylation having some effect on enzyme activity Four protein kinases

are involved in phosphorylation of glycogen synthase: casein kinase, AMP-dependent

protein kinase, protein kinase A, and glycogen synthase kinase 3 (GSK3)

Dephosphorylation of both glycogen phosphorylase and glycogen synthase is

car-ried out by phosphoprotein phosphatase-1 (PP1) The action of PP1 inactivates

glycogen phosphorylase and activates glycogen synthase

Insulin receptor

Insulin

(a)

Glucose

Glucose

Glucose-6-P Allosteric

activation

ATP

ADP

P P

P

P P

Plasma membrane

GLUT4 vesicle

Protein kinase cascade

Protein kinase cascade

GSK3

(inactive)

GSK3 (active)

Glycogen

synthase I

(active)

Glycogen synthase D (inactive)

PP-1

+

+

+ +

+

(b)

Protein phosphorylation and second messenger modulation

Gluconeogenesis Active transport

Glycogen

synthesis

Lipid synthesis

Lipid breakdown

Insulin receptor

Insulin

FIGURE 22.17 (a) Binding of insulin to plasma

mem-brane receptors in the liver and muscles triggers protein kinase cascades that stimulate glycogen synthesis Insulin’s effects include inactivation of GSK3 and stimu-lation of PP1, both actions activating glycogen synthase,

as well as recruitment of GLUT4 to the plasma mem-brane Glucose uptake provides substrate for glycogen synthesis and glucose-6-phosphate, which allosterically activates the otherwise inactive form of glycogen

synthase (b) The metabolic effects of insulin are

medi-ated through protein phosphorylation and second mes-senger modulation.

Trang 8

Hormones Regulate Glycogen Synthesis and Degradation

Storage and utilization of tissue glycogen, maintenance of blood glucose concentra-tion, and other aspects of carbohydrate metabolism are meticulously regulated by

hor-mones, including insulin, glucagon, epinephrine, and the glucocorticoids.

Insulin Is a Response to Increased Blood Glucose The primary hormone

responsi-ble for conversion of glucose to glycogen is insulin (see Figure 5.8) Insulin is secreted

by the -cells in the pancreas within the islets of Langerhans Secretion of insulin is a

re-sponse to increased glucose in the blood When blood glucose levels rise (after a meal, for

example), insulin is secreted from the pancreas into the pancreatic vein, which

emp-ties into the portal vein system (Figure 22.18), so insulin traverses the liver before it

enters the systemic blood supply Insulin acts to rapidly lower blood glucose concen-tration in several ways Insulin stimulates glycogen synthesis and inhibits glycogen breakdown in liver and muscle

Insulin Triggers Glycogen Synthesis When Blood Glucose Rises The action of insulin when blood glucose rises is immediate and powerful During periods be-tween meals, typical human blood glucose levels are 70 to 90 mg/dL Glucose lev-els normally rise to about 150 mg/dL within the first hour following a carbohydrate-rich meal (Figure 22.19) and then return to normal within 2 to 3 hours (For diabetic subjects, whose insulin response is impaired, glucose levels rise after a meal

to 250 mg/dL or even higher and remain high for much longer times.)

A DEEPER LOOK

Carbohydrate Utilization in Exercise

Animals have a remarkable ability to “shift gears” metabolically

dur-ing periods of strenuous exercise or activity Metabolic adaptations

allow the body to draw on different sources of energy (all of which

produce ATP) for different types of activity During periods of

short-term, high-intensity exercise (such as a 100-m dash), most of

the required energy is supplied directly by existing stores of

ATP and creatine phosphate (see figure, part a) Long-term,

low-intensity exercise (such as a 10-km run or a 42.2-km marathon) is

fueled almost entirely by aerobic metabolism Between these

ex-tremes is a variety of activities (an 800-m run, for example) that rely

on anaerobic glycolysis—conversion of glucose to lactate in the

muscles and utilization of the Cori cycle

For all these activities, breakdown of muscle glycogen provides

much of the needed glucose The rate of glycogen consumption

depends on the intensity of the exercise (see figure, part b) By contrast, glucose derived from gluconeogenesis makes only small contributions to total glucose consumed during exercise During prolonged mild exercise, gluconeogenesis accounts for only about 8% of the total glucose consumed During heavy exercise, this percentage becomes even lower

Choice of diet has a dramatic effect on glycogen recovery fol-lowing exhaustive exercise A diet consisting mainly of protein and fat results in very little recovery of muscle glycogen, even af-ter 5 days (see figure, part c) On the other hand, a high-carbo-hydrate diet provides faster restoration of muscle glycogen Even in this case, however, complete recovery of glycogen stores takes about 2 days

100

75

50

25

0

(a)

0

Duration of work (sec)

from phosphocreatine

Anaerobic metabolism

Aerobic metabolism from ATP

24

Muscle glycogen content (grams/kg of muscle)

20

16

12

0

(c)

0 Hours of recovery

8

4

2 hours of exercise

High-carbohydrate diet

No food Fat & protein diet

Light exercise 100

75

50

25

0

(b)

0 Exercise time (min)

Moderate exercise

Heavy exercise

(a) Contributions of the various energy sources to muscle activity during mild exercise (b)

Con-sumption of glycogen stores in fast-twitch muscles during light, moderate, and heavy exercise

(c)Rate of glycogen replenishment following exhaustive exercise (a and c adapted from Rhodes, R., and

Pflanzer, R G., 1992 Human Physiology Philadelphia: Saunders College Publishing; b adapted from Horton, E S., and

Terjung, R L., 1988 Exercise, Nutrition and Energy Metabolism New York: Macmillan.)

Liver

Spleen

Splenic vein

Pancreatic veins Pancreas

Portal vein

FIGURE 22.18 The portal vein system carries pancreatic

secretions such as insulin and glucagon to the liver and

then into the rest of the circulatory system.

Trang 9

Insulin lowers blood glucose by triggering several cascades of reactions that

result in glucose uptake and glycogen synthesis (see Figure 22.17a) An

insulin-triggered protein kinase cascade increases glucose transport into muscle, liver, and

adipose tissues by stimulating exocytotic processes that translocate GLUT4, a

glu-cose transporter, from intracellular vesicles to the plasma membrane (see Figure

22.17a) Large amounts of glucose thus transported into the cell are converted to

6-P, which can be directed to glycogen synthesis (by conversion to

glucose-1-P) Also, glucose-6-P is the allosteric effector that activates the otherwise inactive,

phosphorylated form of glycogen synthase

Binding of insulin to the plasma membrane, in either liver or muscle cells,

trig-gers another protein kinase cascade (see Figure 15.17 and Chapter 32) that results

in phosphorylation and inactivation of glycogen synthase kinase 3 (GSK3) This

ki-nase normally phosphorylates and inactivates glycogen synthase Inhibition of GSK3

means that more of the cell’s glycogen synthase will remain in the

unphosphory-lated, active state (see Figure 22.17a) Insulin also stimulates PP1, which

dephos-phorylates (and activates) glycogen synthase

Several other physiological effects of insulin also serve to lower blood and tissue

glucose levels (see Figure 22.17b) Insulin increases cellular utilization of glucose by

inducing the synthesis of several important glycolytic enzymes, namely, glucokinase,

phosphofructokinase, and pyruvate kinase In addition, insulin acts to inhibit

sev-eral enzymes of gluconeogenesis These various actions enable the organism to

re-spond quickly to increases in blood glucose levels

Glucagon and Epinephrine Stimulate Glycogen Breakdown Catabolism of tissue

glycogen is triggered by the actions of the hormones epinephrine and glucagon

(Fig-ure 22.20) In response to decreased blood glucose, glucagon is released from the -cells

in pancreatic islets of Langerhans This peptide hormone travels through the blood

to specific receptors on liver cell membranes (Glucagon acts on liver and adipose

tissue but not other tissues.) Similarly, signals from the central nervous system cause

release of epinephrine—also known as adrenaline—from the adrenal glands into the

bloodstream Epinephrine acts on liver and muscles When either hormone binds to

its receptor on the outside surface of the cell membrane, a cascade is initiated that

activates glycogen phosphorylase and inhibits glycogen synthase (Figure 22.20) The

result of these actions is tightly coordinated stimulation of glycogen breakdown and

inhibi-tion of glycogen synthesis.

The Phosphorylase Cascade Amplifies the Hormonal Signal Stimulation of

glyco-gen breakdown involves consumption of molecules of ATP at three different steps in

the hormone-sensitive adenylyl cyclase cascade (see Figure 15.17) Note that the

cas-cade mechanism is a means of chemical amplification, because the binding of just a

300

Normal Diabetic

250

0

50 100 150 200

Time, minutes

FIGURE 22.19 A glucose tolerance test involves inges-tion of a glucose soluinges-tion followed by measurements

of blood glucose for about 3 hours Normal subjects exhibit a rise in blood glucose to about 150 mg/dL, followed by a decline to normal values over a 3-hour period In diabetic subjects, blood glucose rises to higher values and remains high for longer periods.

HUMAN BIOCHEMISTRY

von Gierke Disease—A Glycogen-Storage Disease

In 1929, the physician Edgar von Gierke treated a patient with a very

enlarged abdomen The patient’s liver and kidneys were severely

enlarged due to massive accumulations of glycogen, and von Gierke

appropriately called the condition “hepato-nephromegalia

glyco-genica.” Now termed von Gierke’s disease, or Type Ia glycogen

stor-age disease, this condition results from the absence of

glucose-6-phosphatase activity in the affected organs This simple genetic

defect causes a host of difficult complications, including a striking

el-evation of serum triglycerides, excess adipose tissue in the cheeks,

thin extremities, short stature, excessive curvature of the lumbar

spine, and delay of puberty

The absence of glucose-6-phosphatase activity in the liver

blocks the last steps of glycogenolysis and gluconeogenesis,

inter-rupting the recycling of glucose and causing affected individuals

to be hypoglycemic The accumulation of glucose-6-phosphate in the liver leads to greatly increased glycolytic activity, with conse-quent elevation of lactic acid, a condition known more commonly

as lactic acidosis Large amounts of uric acid and lipids are

pro-duced, and the high rates of glycolysis produce excess NADH The treatment of von Gierke’s disease consists of trying to maintain normal levels of glucose in the patient’s serum This of-ten requires oral administration of large amounts of glucose, in its various forms, including, for example, uncooked cornstarch, which acts as a slow-release form of glucose

Trang 10

few molecules of epinephrine or glucagon results in the synthesis of many molecules

of cyclic AMP, which, through the action of cAMP-dependent protein kinase, can ac-tivate many more molecules of phosphorylase kinase and even more molecules of phosphorylase For example, an extracellular level of 1010to 108M epinephrine

prompts the formation of 106M cyclic AMP, and for each protein kinase activated by

cyclic AMP, approximately 30 phosphorylase kinase molecules are activated; these in

OH OH

HO

CH2

NH2+

CH3

muscle

Skeletal muscle

Epinephrine

+ Adenylyl cyclase cAMP ↑

+ cAMP-dependent protein kinase

(PKA)

PFK-2 F-2,6-BPase

+

PFK-1 F-1,6-BPase

+

Gluconeogenesis

+

Blood glucose

+

F-2,6-BP ↓

+ Phosphorylase kinase

+ Glycogen breakdown

Glycogen synthesis Glycolysis

PFK-1

+

PFK-2

Heart

Skeletal muscle

F-2,6-BPase

+

PFK-1

+

Glycolysis

F-2,6-BP ↑

+ Glycogen phosphorylase

association with actin Glucagon

FIGURE 22.20 Glucagon and epinephrine each activate a cascade of reactions that stimulate glycogen break-down and inhibit glycogen synthesis in liver and muscles, respectively The effects of these hormones on other metabolic pathways depend on the tissue In liver, glucagon inhibits glycolysis and stimulates gluconeogenesis, facilitating export of glucose into the bloodstream In muscles, epinephrine stimulates glycolysis to provide energy for contraction These effects all depend on protein phosphorylations by cAMP-dependent protein kinase Note that the liver and heart isoforms of PFK-2/F-2,6-BPase respond oppositely to phosphorylation by PKA Glucagon is a 29-residue peptide with the sequence H3  N-HSEGTFTSDYSKYLDSRRAQDFVQWLMNT-COO 

Ngày đăng: 06/07/2014, 14:20

TỪ KHÓA LIÊN QUAN